Transition state reversible inhibition

Herbicidal Inhibition of Enzymes. The Hst of known en2yme inhibitors contains five principal categories group-specific reagents substrate or ground-state analogues, ie, rapidly reversible inhibitors affinity and photo-affinity labels suicide substrate, or inhibitors and transition-state, or reaction-intermediate, analogues, ie, slowly reversible inhibitors (106). 

P-site ligands inhibit adenylyl cyclases by a noncompetitive, dead-end- (post-transition-state) mechanism (cf. Fig. 6). Typically this is observed when reactions are conducted with Mn2+ or Mg2+ on forskolin- or hormone-activated adenylyl cyclases. However, under- some circumstances, uncompetitive inhibition has been noted. This is typically observed with enzyme that has been stably activated with GTPyS, with Mg2+ as cation. That this is the mechanism of P-site inhibition was most clearly demonstrated with expressed chimeric adenylyl cyclase studied by the reverse reaction. Under these conditions, inhibition by 2 -d-3 -AMP was competitive with cAMP. That is, the P-site is not a site per se, but rather an enzyme configuration and these ligands bind to the post-transition-state configuration from which product has left, but before the enzyme cycles to accept new substrate. Consequently, as post-transition-state inhibitors, P-site ligands are remarkably potent and specific inhibitors of adenylyl cyclases and have been used in many studies of tissue and cell function to suppress cAMP formation. 

Substrate analogs (2) have properties similar to those of one of the substrates of the target enzyme. They are bound by the enzyme, but cannot be converted further and therefore reversibly block some of the enzyme molecules present. A higher substrate concentration is therefore needed to achieve a halfmaximum rate the Michaelis constant increases (B). High concentrations of the substrate displace the inhibitor again. The maximum rate V ax is therefore not influenced by this type of inhibition. Because the substrate and the inhibitor compete with one another for the same binding site on the enzyme, this type of inhibition is referred to as competitive. Analogs of the transition state (3) usually also act competitively. 

Trifluoromethyl /1-thioalkyls and /1-amino alcohols are often good reversible inhibitors of esterases and proteases, respectively. Depending on the enzymes (serine or aspartyl enzymes), fluorinated alcohols are often less efficient inhibitors than the corresponding ketones, which act as analogues of the transition state (vide infra). Nevertheless, fluoroalcohols inhibit hydrolytic enzymes with high inhibition constants (Figure 7.25)." ... 

The ability of fluorinated substituents to prevent the development of a positive charge on the a position has been used to slow down or even inhibit enzymatic processes involving positively charged transition states. According to the case, the observed result can be (1) slowing down the reaction, (2) reversible inhibition, or (3) irreversible inhibition. Various examples are now given. 

Some boronic acid-based enzyme inhibitors undergo strong yet reversible covalent attachment to a nucleophile at the enzyme s active site, while others simply act as competitive inhibitors in their borate conjugate base form. Boronic acid-based inhibition of thrombin has been achieved <93MI109>, and that of P-lactamases has been particularly effective <95TL8399, 96M1688>. When compared to other covalent transition-state analog inhibitors of P-lactamases like phos-... 

H. van Bekkum et al. (72) studied a number of catalysts in the Fischer synthesis starting from l-phenyl-2-butanone 40 (with R, = Ph, R2 = CH3) and phenylhydrazine. The isomeric products are the bulky 2-ethyl-3-phenylindole 45 (with R, = Ph, R2 = CH3) and the linear 2-benzyl-3-methylindole 46 (with R, = Ph, R2 = CH3). Catalysis of the inolization of 40 by soluble as well as solid (e.g. Amberlyst 15) catalysts typically yielded a mixture of the two isomers in a bulky/linear ratio of about 75/25. Zeolite BEA reverses this bulky/linear ratio giving 75% of the linear isomer 46, a result interpreted in terms of restricted transition-state selectivity. Although in zeolite BEA the intraporous formation of 45 is largely suppressed, it is in fact probably not completely inhibited. 

This article describes various approaches to inhibition of enzyme catalysis. Reversible inhibition includes competitive, uncompetitive, mixed inhibition, noncompetitive inhibition, transition state, and slow tight-binding inhibition. Irreversible inhibition approaches include affinity labeling and mechanism-based enzyme inhibition. The kinetics of the various inhibition approaches are summarized, and examples of each type of Inhibition are presented. 

Another class of transition-state inhibitors is the peptide aldehyde inhibitors (Fig. 7). Aldehydes inhibit cysteine, serine, and threonine proteases via a covalent, reversible mechanism, and metaUoproteases using an analogous but nonco-valent mechanism. Aldehydes were discovered in screens for protease inhibitors from microorganisms and generally consist of a peptidyl moiety that binds in the non-prime specificity sites with a C-terminal aldehyde group. These inhibitors are... 

Figure 7 Various transition-state protease inhibitors. Bortezomib is an approved drug for the treatment of multiple myeloma. It is a boronic acid analog that inhibits the proteosome, a threonine protease. The boronic acid moiety can adopt a tetrahedral conformation in the active site. Pepstatin is a peptidyl aspartic acid inhibitor. The reactive statine group binds to the catalytic machinery, and the chiral hydroxyl group of the statine mimics the tetrahedral geometry of the transition state. Idinavir is an approved HIV 1 Protease inhibitor that binds to the active site via a hydroxyethylene transition state isostere. Aldehydes are also transition state analogs, which are susceptible to nucleophilic attack. In cysteine, serine and threonine proteases, this results in a covalent, reversible inhibition mechanism.

Circiunstantial support for this mechanism was supplied by the fact that A-tosyl-Phe-CMK, a specific inhibitor of chymotrypsin, did not react with anhydrochymotrypsin [104]. Although both X-ray crystallographic and NMR studies supported the alkylated hemiketal as the structure of the inhibited enzyme, those studies did not prove whether alkylation or hemiketal formation oecurred first [105, 98]. Carbon-13 NMR studies were also used to determine the pKa (7.88-8.1) of the hemiketal hydroxyl and this finding provided the first evidence that serine proteinases could stabilize the ionized form of the alkylated hemiketal, via hydrogen bonds in the oxyanion hole [106,107]. A series of more recent papers has confirmed that hemiketal formation precedes the alkylation step and has shown that the initial, reversible part of the interaction is made up of two discrete stages (a) formation of a Michaelis complex, followed by (b) hemiketal formation [102, 108]. The requirement of an intermediate hemiketal may mean that chloromethyl ketone (CMK) inhibitors should be considered as transition-state [109] analogue inhibitors (see diseussion in seetion on Aldehydes). 

Physically safer as a mechanistic criterion is reversible inhibition by boronic acids, RB(0H)2, which add the active site serine to form tetrahedral species [RB(0H)20Ser] , which mimic the tetrahedral intermediate/transition state. They also mimic the tetrahedral intermediates in aspartic protease action, however, and are therefore not as definitive. 

Kinetic studies of reversible inhibition by substrate analogs give evidence of the mode of action of the inhibitor and the types of enzyme-inhibitor complex formed, and estimates of their dissociation constants. The complexes may be isolated and sometimes crystallized. Studies of the stabilities, optical properties, and structures of ternary complexes of enzymes, coenzymes, and substrate analog in particular, as stable models of the catalytically active ternary complexes or of the transition state for hydride transfer (61,79,109,115-117), can only be touched upon here there is direct evidence with several enzymes that the binding of coenzymes is firmer in such complexes than in their binary complexes (85,93,118), which supports the indirect, kinetic evidence already mentioned for a similar stabilization in active ternary complexes. 

---